3-325962-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006614.4(CHL1):āc.95A>Gā(p.Gln32Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000998 in 1,603,830 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006614.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHL1 | NM_006614.4 | c.95A>G | p.Gln32Arg | missense_variant | 4/28 | ENST00000256509.7 | NP_006605.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHL1 | ENST00000256509.7 | c.95A>G | p.Gln32Arg | missense_variant | 4/28 | 1 | NM_006614.4 | ENSP00000256509 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152052Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000726 AC: 18AN: 247974Hom.: 0 AF XY: 0.0000820 AC XY: 11AN XY: 134158
GnomAD4 exome AF: 0.000103 AC: 149AN: 1451778Hom.: 0 Cov.: 28 AF XY: 0.0000969 AC XY: 70AN XY: 722700
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152052Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74272
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2023 | The c.95A>G (p.Q32R) alteration is located in exon 4 (coding exon 2) of the CHL1 gene. This alteration results from a A to G substitution at nucleotide position 95, causing the glutamine (Q) at amino acid position 32 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at